Co-trimoxazole and cephalexin. A clinical trial in urinary tract infections in children with spina bifida cystica.
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002506:Cephalexin / Q000009:adverse effects / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use*; D002675:Child, Preschool; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011743:Pyrimidines / Q000627:therapeutic use*; D016135:Spinal Dysraphism / Q000150:complications*; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000209:etiology
D000890:Anti-Infective Agents; D002511:Cephalosporins; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole; D002506:Cephalexin